Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Nasal Spray Flu Vaccines Market by Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine, ), By Application (Hospital, Clinic, Public Health Agency, Other, ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Nasal Spray Flu Vaccines Market by Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine, ), By Application (Hospital, Clinic, Public Health Agency, Other, ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 171138 3300 Pharma & Healthcare 377 246 Pages 4.5 (34)
                                          

The global nasal spray flu vaccines market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for flu vaccines in emerging economies such as China and India. The increasing awareness about the benefits of vaccination among people has also led to an increase in demand for these products. The global nasal spray flu vaccines market is segmented on the basis of type, application, and region. On the basis of type, it can be divided into trivalent flu vaccine, quadrivalent flu vaccine, and others (live attenuated influenza vaccine). On the basis of application, it can be divided into hospital use (inpatient), clinic use (outpatient), public health agency use (community-based), and others (military). On the basis of region, it can be divided into North America (US & Canada), Latin America (Mexico & Brazil), Europe (UK & Germany), Asia Pacific excluding Japan) APEJ) ), Middle East & Africa MEA). 5a) The cost of NSI is lower than IIV due its ease of use and convenience for patients with needle phobia or allergies towards needles.

Some Of The Growth Factors Of This Market:

  1. The global population is increasing, which will lead to an increase in the number of people who are susceptible to flu and other respiratory diseases.
  2. The global population is aging, which will lead to an increase in the number of people who are susceptible to flu and other respiratory diseases.
  3. There has been a shift from seasonal flu vaccines to pandemic vaccines, which will lead to an increase in the demand for nasal spray flu vaccines as well as seasonal flu vaccines.
  4. There has been a shift from injectable influenza vaccine (IIV) towards nasal spray influenza vaccine (NSI), which will lead to an increase in demand for NSI over IIV due its ease of use and convenience for patients with needle phobia or allergies towards needles.

Industry Growth Insights published a new data on “Nasal Spray Flu Vaccines Market”. The research report is titled “Nasal Spray Flu Vaccines Market research by Types (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine, ), By Applications (Hospital, Clinic, Public Health Agency, Other, ), By Players/Companies Sanofi Pasteur, AstraZeneca, CSL, Abbott, GlaxoSmithKline, Serum Institute of India”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Nasal Spray Flu Vaccines Market Research Report

By Type

Trivalent Flu Vaccine, Quadrivalent Flu Vaccine,

By Application

Hospital, Clinic, Public Health Agency, Other,

By Companies

Sanofi Pasteur, AstraZeneca, CSL, Abbott, GlaxoSmithKline, Serum Institute of India

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

246

Number of Tables & Figures

173

Customization Available

Yes, the report can be customized as per your need.


Global Nasal Spray Flu Vaccines Industry Outlook


Global Nasal Spray Flu Vaccines Market Report Segments:

The global Nasal Spray Flu Vaccines market is segmented on the basis of:

Types

Trivalent Flu Vaccine, Quadrivalent Flu Vaccine,

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Clinic, Public Health Agency, Other,

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Sanofi Pasteur
  2. AstraZeneca
  3. CSL
  4. Abbott
  5. GlaxoSmithKline
  6. Serum Institute of India

Global Nasal Spray Flu Vaccines Market Overview


Highlights of The Nasal Spray Flu Vaccines Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Trivalent Flu Vaccine
    2. Quadrivalent Flu Vaccine
  1. By Application:

    1. Hospital
    2. Clinic
    3. Public Health Agency
    4. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Nasal Spray Flu Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Nasal Spray Flu Vaccines Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Nasal spray flu vaccines are a type of vaccine that is delivered through the nose. They are typically used in people who do not have access to other forms of vaccination, such as those with cancer or immune system disorders.

Some of the key players operating in the nasal spray flu vaccines market are Sanofi Pasteur, AstraZeneca, CSL, Abbott, GlaxoSmithKline, Serum Institute of India.

The nasal spray flu vaccines market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Nasal Spray Flu Vaccines Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Nasal Spray Flu Vaccines Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Nasal Spray Flu Vaccines Market - Supply Chain
   4.5. Global Nasal Spray Flu Vaccines Market Forecast
      4.5.1. Nasal Spray Flu Vaccines Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Nasal Spray Flu Vaccines Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Nasal Spray Flu Vaccines Market Absolute $ Opportunity

5. Global Nasal Spray Flu Vaccines Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Nasal Spray Flu Vaccines Market Size and Volume Forecast by Type
      5.3.1. Trivalent Flu Vaccine
      5.3.2. Quadrivalent Flu Vaccine
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Nasal Spray Flu Vaccines Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Nasal Spray Flu Vaccines Market Size and Volume Forecast by Application
      6.3.1. Hospital
      6.3.2. Clinic
      6.3.3. Public Health Agency
      6.3.4. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Nasal Spray Flu Vaccines Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Nasal Spray Flu Vaccines Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Nasal Spray Flu Vaccines Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Nasal Spray Flu Vaccines Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Nasal Spray Flu Vaccines Demand Share Forecast, 2019-2026

9. North America Nasal Spray Flu Vaccines Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Nasal Spray Flu Vaccines Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Nasal Spray Flu Vaccines Market Size and Volume Forecast by Application
      9.4.1. Hospital
      9.4.2. Clinic
      9.4.3. Public Health Agency
      9.4.4. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Nasal Spray Flu Vaccines Market Size and Volume Forecast by Type
      9.7.1. Trivalent Flu Vaccine
      9.7.2. Quadrivalent Flu Vaccine
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Nasal Spray Flu Vaccines Demand Share Forecast, 2019-2026

10. Latin America Nasal Spray Flu Vaccines Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Nasal Spray Flu Vaccines Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Nasal Spray Flu Vaccines Market Size and Volume Forecast by Application
      10.4.1. Hospital
      10.4.2. Clinic
      10.4.3. Public Health Agency
      10.4.4. Other
    10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Nasal Spray Flu Vaccines Market Size and Volume Forecast by Type
      10.7.1. Trivalent Flu Vaccine
      10.7.2. Quadrivalent Flu Vaccine
    10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Nasal Spray Flu Vaccines Demand Share Forecast, 2019-2026

11. Europe Nasal Spray Flu Vaccines Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Nasal Spray Flu Vaccines Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Nasal Spray Flu Vaccines Market Size and Volume Forecast by Application
      11.4.1. Hospital
      11.4.2. Clinic
      11.4.3. Public Health Agency
      11.4.4. Other
    11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Nasal Spray Flu Vaccines Market Size and Volume Forecast by Type
      11.7.1. Trivalent Flu Vaccine
      11.7.2. Quadrivalent Flu Vaccine
    11.8. Basis Point Share (BS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Nasal Spray Flu Vaccines Demand Share, 2019-2026

12. Asia Pacific Nasal Spray Flu Vaccines Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Nasal Spray Flu Vaccines Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Nasal Spray Flu Vaccines Market Size and Volume Forecast by Application
      12.4.1. Hospital
      12.4.2. Clinic
      12.4.3. Public Health Agency
      12.4.4. Other
    12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Nasal Spray Flu Vaccines Market Size and Volume Forecast by Type
      12.7.1. Trivalent Flu Vaccine
      12.7.2. Quadrivalent Flu Vaccine
    12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Nasal Spray Flu Vaccines Demand Share, 2019-2026

13. Middle East & Africa Nasal Spray Flu Vaccines Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Nasal Spray Flu Vaccines Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Nasal Spray Flu Vaccines Market Size and Volume Forecast by Application
      13.4.1. Hospital
      13.4.2. Clinic
      13.4.3. Public Health Agency
      13.4.4. Other
    13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Nasal Spray Flu Vaccines Market Size and Volume Forecast by Type
      13.7.1. Trivalent Flu Vaccine
      13.7.2. Quadrivalent Flu Vaccine
    13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Nasal Spray Flu Vaccines Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Nasal Spray Flu Vaccines Market: Market Share Analysis
   14.2. Nasal Spray Flu Vaccines Distributors and Customers
   14.3. Nasal Spray Flu Vaccines Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Sanofi Pasteur
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. AstraZeneca
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. CSL
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Abbott
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. GlaxoSmithKline
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Serum Institute of India
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. COMPANY7
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us